Amgen Inc.

AMGN 298.50 USD NASDAQ (XNGS)

Profile

Company Overview

Amgen Inc. is a leading biotechnology company focused on the discovery, development, manufacturing, and marketing of human therapeutics.

Established in 1980 and headquartered in Thousand Oaks, California, Amgen is recognized for pioneering biologic treatments and having a robust pipeline that targets critical areas like oncology, cardiovascular, and nephrology.

The company has harnessed advanced technology platforms and deep scientific expertise to deliver innovative medicines such as Neulasta, Enbrel, and Prolia, which are significant players in the health care sector.

Amgen serves markets globally, impacting the biotech industry by transforming the ways diseases are treated.

Its investment in state-of-the-art manufacturing facilities and research makes it a significant entity in the pharmaceutical landscape, contributing to long-term health care solutions.

Website: https://www.amgen.com

Company Details

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
Employees
28000
Last updated: 09/29/2025 4:37 a.m.